U.S. flag

An official website of the United States government

NCBI Bookshelf. A service of the National Library of Medicine, National Institutes of Health.

StatPearls [Internet]. Treasure Island (FL): StatPearls Publishing; 2026 Jan-.

Cover of StatPearls

StatPearls [Internet].

Show details

Embryology, Ovarian Follicle Development

; .

Author Information and Affiliations

Last Update: August 3, 2025.

Introduction

The ovary has 2 primary functions. First, it produces hormones that drive the female reproductive system, principally estrogen and progesterone. Second, it controls the development, selection, and release of mature oocytes for fertilization. This process, known as ovarian folliculogenesis, begins while the female is in utero. After puberty, primordial follicles undergo a multi-step process to transform into mature, pre-ovulatory follicles.

Development

Ovarian follicular development begins while the female fetus is in utero. During the fifth week of pregnancy, a female fetus's ovary contains about 500 to 1300 primordial germ cells.[1] These cells undergo mitosis, and by the 20th week of pregnancy, the female fetus has approximately 6 to 7 million germ cells. Once mitosis is complete, the germ cells enter meiosis and arrest in meiotic prophase I, forming germ cell cysts. Peripartum, each germ cell cyst regresses to form a primordial follicle containing an oocyte and a single layer of nourishing granulosa cells. Many germ cells are lost during this process, and the female is born with 1 to 2 million primordial follicles. By the time she reaches puberty, approximately 400,000 to 500,000 primordial follicles remain. After menarche, approximately 1000 follicles are lost each month. After the age of 35, the rate of follicular loss increases.[2][3]

Ovarian follicle development occurs in 2 distinct phases—the gonadotropin-independent growth (pre-antral phase) and the gonadotropin-dependent growth (antral phase).[4] Gonadotropins, which include follicle-stimulating hormone (FSH) and luteinizing hormone (LH), are produced and released by the anterior pituitary gland in response to stimulation by gonadotropin-releasing hormone from the hypothalamus.[5] FSH promotes follicular growth by stimulating granulosa cell proliferation, whereas LH regulates ovulation.

Ovarian follicular development occurs in the peripheral cortex of the ovary. Approximately 1 year is required for a primordial follicle to mature before ovulation (see Image. Ovarian Follicle Development: Oocytes and Primary Follicles in Early Stages). Most of this time is spent in the gonadotropin-independent (pre-antral) phase. Gonadotropin-independent growth relies on local growth factors, beginning with the maturation of the primordial follicle and ending before the follicle develops a fluid-filled space. Primordial follicles transition into primary follicles through oocyte enlargement and granulosa cell layer proliferation, which then start to express FSH receptors. As primary follicles become secondary follicles, the simple cuboidal epithelium of the primary follicle transforms into stratified columnar epithelium. The primary follicle stroma develops a blood supply and differentiates into the theca interna and theca externa. The theca interna develops LH receptors. The FSH and LH receptors enable the follicles to respond to their respective gonadotropins.[6]

Further maturation of secondary follicles and selection of a dominant follicle for ovulation are gonadotropin-dependent.[7] FSH binds to FSH receptors in the granulosa cell layer of the secondary follicle. In response to FSH stimulation, follicles continue to grow and develop a fluid-filled space. This space is referred to as an antrum and contains secretory material from the growing oocyte and granulosa cells. LH binds to LH receptors of the theca interna, resulting in the production of androgens. These androgens facilitate not only follicular growth but also promote follicular loss through apoptosis. As ovarian follicles mature, the larger follicles can use the enzyme aromatase to convert these androgens into estrogen.

Increasing levels of estrogen send a negative feedback signal to the hypothalamic-pituitary-adrenal axis, decreasing the circulating levels of FSH (see Image. Hypothalamic-Pituitary-Gonadal Axis). Large follicles remain sensitive to the decreasing levels of FSH. A large follicle is selected as the dominant follicle and continues to mature through a rapid proliferation of granulosa and theca cells. The antrum also enlarges rapidly. Smaller developing follicles that are not selected as the dominant follicle during the cycle undergo degeneration due to reduced sensitivity to FSH associated with their smaller size. Granulosa cells of the dominant pre-ovulatory follicle develop high concentrations of LH receptors and become responsive to the LH surge. The LH surge is caused by further increases in circulating estrogen made by the pre-ovulatory follicle and results in ovulation. During ovulation, the follicle releases its mature oocyte, which is then available for fertilization (see Image. Mature Ovarian Follicle).[8]

After ovulation, the empty follicle develops into the corpus luteum, as granulosa and theca cells differentiate into granulosa luteal and theca luteal cells, respectively. The corpus luteum secretes progesterone and estrogen to support implantation and early pregnancy. If implantation does not occur, the corpus luteum degenerates into a connective tissue structure known as the corpus albicans.

Clinical Significance

Abnormal follicular development is a hallmark of polycystic ovarian syndrome (PCOS), a disorder characterized by enlarged polycystic ovaries, abnormal menstrual bleeding, and increased androgen production.[9] Compared to females without PCOS, the ovaries of patients with PCOS have at least twice the number of growing pre-antral and antral follicles. Additionally, these follicles do not develop properly. Many follicles do not progress through the antral stage; they accumulate excess fluid, lose their granulosa cell border, and degenerate into cystic structures.[10] Patients with PCOS also have increased levels of LH, androgens, and insulin and decreased levels of FSH.[11] The precise mechanism resulting in the cystic changes associated with PCOS remains unknown. The cystic changes can cause anovulatory infertility.[12]

Premature ovarian failure is rare and most commonly presents as a loss of ovarian reserve, defined as a decreased number of primordial follicles before the age of 40.[13] Patients present with absent menstruation and disrupted ovarian follicular development, leading to symptoms of menopause and infertility. Premature ovarian failure can also present in patients who never reach menarche because of ovarian dysgenesis.

A proper understanding of ovarian follicular development is essential when counseling patients about fertility. Healthcare providers must understand and explain an assessment of a patient's ovarian follicular reserve and the potential benefit of assisted reproductive technology, including in vitro fertilization and controlled ovarian hyperstimulation.[14] As previously discussed, women younger than 35 lose approximately 1000 primordial follicles per month, and this rate increases in females older than 35. If a patient needs or desires assisted reproductive technology, it is essential to assess their ovarian reserve to maintain patient safety and define expectations. Ovarian reserve status is related to the production of antral follicles, which can be measured through transvaginal ultrasound. A decreased antral follicle count correlates with a lower ovarian reserve and decreased fertility. Patients with a smaller ovarian reserve are less likely to respond to ovarian stimulation, and women with a large ovarian reserve are at an increased risk of severe adverse effects. Understanding a patient's ovarian reserve enables healthcare providers to determine reproductive capability before and during assisted reproductive technology and establish an appropriate treatment plan.[15]

Review Questions

Ovarian Follicle Development: Oocytes and Primary Follicles in Early Stages

Figure

Ovarian Follicle Development: Oocytes and Primary Follicles in Early Stages. The image shows visible structures including ovarian follicles, oocytes, and a small primary follicle. Contributed by F Farci, MD

Hypothalamic-Pituitary-Gonadal Axis

Figure

Hypothalamic-Pituitary-Gonadal Axis. GnRH, gonadotropin-releasing hormone; LH, luteinizing hormone; FSH, follicle-stimulating hormone. Contributed by P Koopman, PhD, FAA 

Mature Ovarian Follicle

Figure

Mature Ovarian Follicle. The image depicts a mature ovarian follicle, also known as a Graafian follicle. In this stage, the oocyte has completed the first meiotic division (2N haploid) and is surrounded by granulosa cells. The cavity formed in the middle (more...)

References

1.
Overland MR, Li Y, Derpinghaus A, Aksel S, Cao M, Ladwig N, Cunha GR, Himelreich-Perić M, Baskin LS. Development of the human ovary: Fetal through pubertal ovarian morphology, folliculogenesis and expression of cellular differentiation markers. Differentiation. 2023 Jan-Feb;129:37-59. [PubMed: 36347737]
2.
Sun YC, Sun XF, Dyce PW, Shen W, Chen H. The role of germ cell loss during primordial follicle assembly: a review of current advances. Int J Biol Sci. 2017;13(4):449-457. [PMC free article: PMC5436565] [PubMed: 28529453]
3.
Vollenhoven B, Hunt S. Ovarian ageing and the impact on female fertility. F1000Res. 2018;7 [PMC free article: PMC6259486] [PubMed: 30542611]
4.
Orisaka M, Miyazaki Y, Shirafuji A, Tamamura C, Tsuyoshi H, Tsang BK, Yoshida Y. The role of pituitary gonadotropins and intraovarian regulators in follicle development: A mini-review. Reprod Med Biol. 2021 Apr;20(2):169-175. [PMC free article: PMC8022101] [PubMed: 33850449]
5.
Casati L, Ciceri S, Maggi R, Bottai D. Physiological and pharmacological overview of the gonadotropin releasing hormone. Biochem Pharmacol. 2023 Jun;212:115553. [PubMed: 37075816]
6.
Jo M, Brännström M, Akins JW, Curry TE. New insights into the ovulatory process in the human ovary. Hum Reprod Update. 2025 Jan 01;31(1):21-47. [PMC free article: PMC11696709] [PubMed: 39331957]
7.
Gershon E, Dekel N. Newly Identified Regulators of Ovarian Folliculogenesis and Ovulation. Int J Mol Sci. 2020 Jun 26;21(12) [PMC free article: PMC7349727] [PubMed: 32604954]
8.
Soygur B, Laird DJ. Ovary Development: Insights From a Three-Dimensional Imaging Revolution. Front Cell Dev Biol. 2021;9:698315. [PMC free article: PMC8351467] [PubMed: 34381780]
9.
Stener-Victorin E, Teede H, Norman RJ, Legro R, Goodarzi MO, Dokras A, Laven J, Hoeger K, Piltonen TT. Polycystic ovary syndrome. Nat Rev Dis Primers. 2024 Apr 18;10(1):27. [PubMed: 38637590]
10.
Su P, Chen C, Sun Y. Physiopathology of polycystic ovary syndrome in endocrinology, metabolism and inflammation. J Ovarian Res. 2025 Feb 20;18(1):34. [PMC free article: PMC11841159] [PubMed: 39980043]
11.
Chauvin S, Cohen-Tannoudji J, Guigon CJ. Estradiol Signaling at the Heart of Folliculogenesis: Its Potential Deregulation in Human Ovarian Pathologies. Int J Mol Sci. 2022 Jan 03;23(1) [PMC free article: PMC8745567] [PubMed: 35008938]
12.
Liu X, Zhang J, Wang S. Global, regional, and national burden of infertility attributable to PCOS, 1990-2019. Hum Reprod. 2024 Jan 05;39(1):108-118. [PubMed: 38011904]
13.
França MM, Mendonca BB. Genetics of ovarian insufficiency and defects of folliculogenesis. Best Pract Res Clin Endocrinol Metab. 2022 Jan;36(1):101594. [PubMed: 34794894]
14.
Graham ME, Jelin A, Hoon AH, Wilms Floet AM, Levey E, Graham EM. Assisted reproductive technology: Short- and long-term outcomes. Dev Med Child Neurol. 2023 Jan;65(1):38-49. [PMC free article: PMC9809323] [PubMed: 35851656]
15.
Fleming R, Seifer DB, Frattarelli JL, Ruman J. Assessing ovarian response: antral follicle count versus anti-Müllerian hormone. Reprod Biomed Online. 2015 Oct;31(4):486-96. [PubMed: 26283017]

Disclosure: Emily Cox declares no relevant financial relationships with ineligible companies.

Disclosure: Veronica Takov declares no relevant financial relationships with ineligible companies.

Copyright © 2026, StatPearls Publishing LLC.

This book is distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International (CC BY-NC-ND 4.0) ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ), which permits others to distribute the work, provided that the article is not altered or used commercially. You are not required to obtain permission to distribute this article, provided that you credit the author and journal.

Bookshelf ID: NBK532300PMID: 30335333

Views

  • PubReader
  • Print View
  • Cite this Page

Related information

  • PMC
    PubMed Central citations
  • PubMed
    Links to PubMed

Similar articles in PubMed

See reviews...See all...

Recent Activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...